Inhibition of melanocortin-4 receptor dimerization by substitutions in intracellular loop 2
Carolin L. Piechowski(Charité - Universitätsmedizin Berlin), Heike Biebermann(Humboldt-Universität zu Berlin), Jessica Mühlhaus(Charité - Universitätsmedizin Berlin), Anne Rediger(Charité - Universitätsmedizin Berlin), Annette Grüters(Unknown), Juliane Pratzka(Charité - Universitätsmedizin Berlin), Heiko Krude(Humboldt-Universität zu Berlin), Anne Müller(Humboldt-Universität zu Berlin), Patrick Tarnow(Humboldt-Universität zu Berlin), Christina Lagemann(Humboldt-Universität zu Berlin), Gunnar Kleinau(Humboldt-Universität zu Berlin)
Cited by 40
Related Papers
Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans
|Nature Genetics|1998|1.7k
Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation
|The Lancet|2004|707
European Society for Paediatric Endocrinology Consensus Guidelines on Screening, Diagnosis, and Management of Congenital Hypothyroidism
|The Journal of Clinical Endocrinology & Metabolism|2014|569
PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis
|Nature Genetics|1998|503
Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist
|New England Journal of Medicine|2016|480